Literature DB >> 21149476

Vascular inflammation stratified by C-reactive protein and low-density lipoprotein cholesterol levels: analysis with 18F-FDG PET.

Hye Jin Yoo1, Sungeun Kim, Man Sik Park, Sae Jeong Yang, Tae Nyun Kim, Ji A Seo, Sin Gon Kim, Nan Hee Kim, Hong Seog Seo, Sei Hyun Baik, Dong Seop Choi, Kyung Mook Choi.   

Abstract

UNLABELLED: We examined the severity of vascular inflammation in healthy individuals without hyperlipidemia but with elevated high-sensitivity C-reactive protein (hsCRP) using 18F-FDG PET, which is a promising imaging technique for the assessment of vascular inflammation within atherosclerotic plaques.
METHODS: Vascular inflammation in the carotid arterial wall, represented as the target-to-background ratio (TBR), was measured using 18F-FDG PET in 120 healthy subjects without a history of cardiovascular diseases.
RESULTS: Subjects with high hsCRP (≥2 mg/L) and low low-density lipoprotein cholesterol (LDL-C) (<130 mg/dL) levels had a significantly higher maximum TBR than did those with low hsCRP (<2 mg/L) and low LDL-C levels (<130 mg/dL) or low hsCRP (<2 mg/L) and high LDL-C levels (≥130 mg/dL) (1.29±0.13, 1.12±0.10, and 1.16±0.05, respectively), even though there were no significant differences in the carotid intima-media thickness. The maximum TBR values had the strongest positive correlation with hsCRP level among the various cardiovascular risk factors (r=0.68, P<0.01). However, other emerging inflammatory markers such as lipoprotein-associated phospholipase A(2) or monocyte chemoattractant protein-1 were not coherently associated with TBR values. Multiple stepwise regression analyses showed that hsCRP and diastolic blood pressure were independent decisive factors for maximum TBR, whereas age, diastolic blood pressure, and LDL-C were factors that determined the maximum intima-media thickness.
CONCLUSION: Vascular inflammation measured using 18F-FDG PET was increased in healthy individuals without hyperlipidemia but with elevated hsCRP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21149476     DOI: 10.2967/jnumed.110.080838

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  20 in total

Review 1.  Molecular imaging in atherosclerosis: FDG PET.

Authors:  David Rosenbaum; Antoine Millon; Zahi A Fayad
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

Review 2.  The advancing clinical impact of molecular imaging in CVD.

Authors:  Eric A Osborn; Farouc A Jaffer
Journal:  JACC Cardiovasc Imaging       Date:  2013-12

3.  The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers.

Authors:  Yen-Wen Wu; Hsian-Li Kao; Chi-Lun Huang; Ming-Fong Chen; Lian-Yu Lin; Yi-Chih Wang; Yen-Hung Lin; Hung-Ju Lin; Kai-Yuan Tzen; Ruoh-Fang Yen; Yu-Chiao Chi; Por-Jau Huang; Wei-Shiung Yang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-23       Impact factor: 9.236

4.  Carotid Artery FDG Uptake May Serve as a Biomarker for Cardiovascular Risk Stratification in Asymptomatic Adults.

Authors:  Dong Hyun Lee; Su Jin Lee; Duck-Joo Lee; Soo Hyun Kwon; Kyung-Sook Jo; Young-Sil An; Joon-Kee Yoon
Journal:  Nucl Med Mol Imaging       Date:  2014-04-29

5.  Apolipoprotein A-I inhibits LPS-induced atherosclerosis in ApoE(-/-) mice possibly via activated STAT3-mediated upregulation of tristetraprolin.

Authors:  Kai Yin; Shi-lin Tang; Xiao-hua Yu; Guang-hui Tu; Rong-fang He; Jin-feng Li; Di Xie; Qing-jun Gui; Yu-chang Fu; Zhi-sheng Jiang; Jian Tu; Chao-ke Tang
Journal:  Acta Pharmacol Sin       Date:  2013-04-08       Impact factor: 6.150

6.  Aortic vascular inflammation in psoriasis is associated with HDL particle size and concentration: a pilot study.

Authors:  Yiding Yu; Nikhil Sheth; Parasuram Krishnamoorthy; Babak Saboury; Anna Raper; Amanda Baer; Rachel Ochotony; Julia Doveikis; Stephanie Derohannessian; Abby S Van Voorhees; Drew A Torigian; Abass Alavi; Joel M Gelfand; Nehal N Mehta
Journal:  Am J Cardiovasc Dis       Date:  2012-10-23

Review 7.  PET imaging of inflammation in atherosclerosis.

Authors:  Jason M Tarkin; Francis R Joshi; James H F Rudd
Journal:  Nat Rev Cardiol       Date:  2014-06-10       Impact factor: 32.419

8.  Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study.

Authors:  Raphaël Duivenvoorden; Venkatesh Mani; Mark Woodward; David Kallend; Gabriela Suchankova; Valentin Fuster; James H F Rudd; Ahmed Tawakol; Michael E Farkouh; Zahi A Fayad
Journal:  JACC Cardiovasc Imaging       Date:  2013-10

9.  Positive association between serum level of glyceraldehyde-derived advanced glycation end products and vascular inflammation evaluated by [(18)F]fluorodeoxyglucose positron emission tomography.

Authors:  Nobuhiro Tahara; Sho-ichi Yamagishi; Masayoshi Takeuchi; Akihiro Honda; Atsuko Tahara; Yoshikazu Nitta; Norihiro Kodama; Minori Mizoguchi; Hayato Kaida; Masatoshi Ishibashi; Naofumi Hayabuchi; Takanori Matsui; Tsutomu Imaizumi
Journal:  Diabetes Care       Date:  2012-08-21       Impact factor: 19.112

10.  Glucose metabolic trapping in mouse arteries: nonradioactive assay of atherosclerotic plaque inflammation applicable to drug discovery.

Authors:  Richard G Conway; Eyassu Chernet; David C De Rosa; Robert J Benschop; Anne B Need; Emily C Collins; James S Bean; J Michael Kalbfleisch; Mark D Rekhter
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.